|
2025
|
Invention
|
Saccharide coupled microsphere, methods of preparation and applications thereof.
The present inv... |
|
2024
|
Invention
|
Immunogenic compositions against enteric diseases and methods for its preparation thereof.
The p... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the treatmen... |
|
|
Invention
|
Methods for enhancing antibody productivity in mammalian cell culture and minimizing aggregation ... |
|
|
Invention
|
Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine... |
|
|
Invention
|
Method for manufacturing viral vaccines and compositions thereof. Present invention provides a me... |
|
|
Invention
|
Meningococcal protein based vaccine formulations and methods for manufacturing thereof. Present i... |
|
2023
|
Invention
|
Method for manufacturing recombinant transferrin binding proteins and vaccine compositions comrpi... |
|
|
G/S
|
Medicinal preparations and substances; Pharmaceutical preparations and substances. |
|
|
Invention
|
Freeze-dried viral vaccine compositions and method of manufacturing thereof. The present disclosu... |
|
|
G/S
|
Medicinal preparations and substances; pharmaceutical preparations and substances. |
|
|
Invention
|
Method for removal of impurities from bacterial capsular polysaccharide based preparations. The p... |
|
|
Invention
|
Multivalent covid-19 vaccines based on adenoviral vectors. The present invention relates to the c... |
|
2022
|
Invention
|
Freeze-dried viral combination vaccine compositions and process for preparation thereof.
The pre... |
|
|
Invention
|
Freeze-dried viral combination vaccine compositions and process for preparation thereof. : FREEZE... |
|
|
Invention
|
Method for monitoring stability of polysaccharide-protein conjugate vaccines.
The present disclo... |
|
|
Invention
|
Immunogenic composition comprising cyaa-derived polypeptide promoting a th1/th17-oriented immune ... |
|
|
Invention
|
Deoptimized sars-cov-2 variants and methods and uses thereof.
Described herein are modified SARS... |
|
2021
|
Invention
|
Methods for simultaneous fragmentation and purification of bacterial polysaccharides.
The presen... |
|
|
Invention
|
Methods for simultaneous fragmentation and purification of bacterial polysaccharides. The present... |
|
|
G/S
|
Vaccine for human use |
|
|
G/S
|
Vaccine for human use. |
|
|
G/S
|
Vaccine for human use. |
|
|
Invention
|
Active booster immunization against tetanus, diphtheria and pertussis.
The present disclosure re... |
|
|
Invention
|
Active booster immunization against tetanus, diphtheria and pertussis. The present disclosure rel... |
|
|
Invention
|
Deoptimized sars-cov-2 and methods and uses thereof.
Described herein are modified SARS-CoV-2 co... |
|
2020
|
G/S
|
Human pharmaceutical vaccines; human vaccine preparations. |
|
|
G/S
|
Vaccine. |
|
|
G/S
|
Vaccine |
|
|
G/S
|
Medicinal and pharmaceutical preparations, namely, anti-infective preparations, antiviral prepara... |
|
|
G/S
|
Vaccines, medicinal and pharmaceutical preparations for immunization against meningococcal disease |
|
|
G/S
|
Vaccines, medicinal and pharmaceutical preparations. |
|
|
G/S
|
Vaccine against Meningococcal disease. |
|
|
G/S
|
Medicinal and pharmaceutical preparations, namely, human vaccine preparations, anti-toxins in the... |
|
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
|
Invention
|
Method for obtaining purified bacterial polysaccharides. The present disclosure relates to a meth... |
|
|
Invention
|
Immunogenic compositions against enteric diseases and methods for its preparation thereof. Salmon... |
|
|
Invention
|
Stabilized live attenuated influenza vaccine compositions. The present disclosure provides compos... |
|
|
Invention
|
Live attenuated influenza vaccine composition and process for preparation thereof. The present di... |
|
2019
|
Invention
|
Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions o... |
|
|
Invention
|
Combination vaccine composition comprising reduced dose inactivated poliovirus and method for pre... |
|
2018
|
Invention
|
Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and proc... |
|
|
Invention
|
Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogeni... |
|
|
Invention
|
An immunogenic composition having improved stability, enhanced immunogenicity and reduced reactog... |
|
2017
|
Invention
|
Improved methods for enhancing antibody productivity in mammalian cell culture and minimizing agg... |
|
|
Invention
|
Multivalent vaccine composition. Stable, immunogenic combination vaccine(s) comprising a mixture ... |
|
|
Invention
|
Multivalent vaccine composition. The present invention relates to stable, immunogenic combination... |
|
2016
|
Invention
|
Feeding strategies and purification processes for monoclonal antibody production. This invention ... |
|
2015
|
Invention
|
Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compo... |
|
|
Invention
|
Highly sensitive immunoassay for rapid quantification of meningococcal capsular polysaccharide an... |
|
2014
|
Invention
|
Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-cbt), in the pre... |
|
|
Invention
|
Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2h)-one (2-cpo), in ... |
|
2013
|
Invention
|
Production of high yields of bacterial polysaccharides. Neisseria meningitidis X polysaccharide. |
|
|
Invention
|
Adjuvant formulations and methods. The present invention is directed to methods for administering... |
